Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 606 Cyclophosphamide 546 Magnetic Resonance Spectroscopy 527 Radiotherapy 514 Specimen Handling 506 Nivolumab 412 Cisplatin 381 Carboplatin 369 Biopsy 306 Blood Specimen Collection 304 Radiosurgery 290 Paclitaxel 281 Gemcitabine 271 Surveys and Questionnaires 270 Standard of Care 267 Drug Therapy 264 fludarabine 263 Dexamethasone 263 Bevacizumab 253 venetoclax 251 Oxaliplatin 209 Capecitabine 201 Rituximab 199 Radiation 192 Fluorouracil 189 Ipilimumab 188 durvalumab 185 Doxorubicin 179 Etoposide 177 atezolizumab 175

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × secukinumab × 1 year × Clear all

NCT07237594 2026-06-04

REPLAY

Duke University

Phase 1 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡